1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Acral Melanoma: new trials by email Literature Review of Acral Melanoma trials Research Report on Acral Melanoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Camrelizumab in Combination With Apatinib and Temozolomide as First-line Treatment in Advanced Acral Melanoma camrelizumab+apatinib+TMZ, camrelizumab+apatinib, camrelizumab - Acral Melanoma | Phase 3 | Recruiting | Peking University Cancer Hospital & Institute | 140 | 2023-03-21 | 2023-09-06 |
camrelizumab (1)
Peking University Cancer Hospital & Institute (1)
China (1)
Jun Guo, Dr (1)